1 – 10 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Expression of Stress-Induced Genes in Bronchoalveolar Lavage Cells and Lung Fibroblasts from Healthy and COPD Subjects
(
- Contribution to journal › Article
-
Mark
EUFOREUM Berlin 2023 : Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus
(
- Contribution to journal › Article
-
Mark
Expiratory and inspiratory resistance and reactance from respiratory oscillometry defining expiratory flow limitation in obstructive lung diseases
2024) In Clinical Physiology and Functional Imaging(
- Contribution to journal › Article
-
Mark
Treatment Preferences for Acute Allergic Reactions : A Discrete Choice Experiment
(
- Contribution to journal › Article
-
Mark
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma
(
- Contribution to journal › Article
-
Mark
Altered hypoxia-induced cellular responses and inflammatory profile in lung fibroblasts from COPD patients compared to control subjects
(
- Contribution to journal › Article
-
Mark
Disease burden and unmet need for acute allergic reactions – A patient perspective
(
- Contribution to journal › Article
-
Mark
Multi-Disciplinary Expert Perspective on the Management of Type 2 Inflammation-Driven Severe CRSwNP : A Brief Overview of Pathophysiology and Recent Clinical Insights
(
- Contribution to journal › Article
-
Mark
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
(
- Contribution to journal › Article
-
Mark
Metabolic pathways in immune senescence and inflammaging : Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
(
- Contribution to journal › Article